StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3028% above fair value
$530.76−22.39 (-4.05%)

Close on Nov 3, 2026Market cap $134.53BP/E 30.9Yield –

Vertex Pharmaceuticals Item 2(c) / Item 5 by Quarter

Item 2(c) / Item 5 — Quarterly volume-weighted average price paid per share ($/sh) ($)

Vertex Pharmaceuticals Item 2(c) / Item 5: $440 in Q2 2026, down 3.1% from a year earlier.

Latest, Q2 2026
440
Period ended Jun 30, 2026
Change on a year earlier
-3.1%
454 in Q2 2025
History
27 quarters
Since Q1 2018
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Total | 1,033,652 | $ 440.17 | 1,033,652 | $ 2,582,008,580”

Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗

Reported in Form 10-Q Part II Item 2(c) & Form 10-K Item 5.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedItem 2(c) / Item 5 — Quarterly volume-weighted average price paid per share ($/sh) ($)Year on yearSource
Q2 2026Jun 30, 2026440-3.1%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Q1 2026Mar 31, 2026465+4.0%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Q4 2025Dec 31, 2025409-8.0%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Q3 2025Sep 30, 2025397-17.4%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Q2 2025Jun 30, 2025454+5.8%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
Q1 2025Mar 31, 2025447+6.9%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗
Q4 2024Dec 31, 2024445+23.3%Form 10-K (vrtx-20241231.htm, filed 2025-02-13) ↗
Q3 2024Sep 30, 2024481+37.8%Form 10-Q (vrtx-20240930.htm, filed 2024-11-05) ↗
Q2 2024Jun 30, 2024429+33.7%Form 10-Q (vrtx-20240630.htm, filed 2024-08-02) ↗
Q1 2024Mar 31, 2024418+41.6%Form 10-Q (vrtx-20240331.htm, filed 2024-05-07) ↗
Q4 2023Dec 31, 2023361–Form 10-K (vrtx-20231231.htm, filed 2024-02-15) ↗
Q3 2023Sep 30, 2023349–Form 10-Q (vrtx-20230930.htm, filed 2023-11-07) ↗
Q2 2023Jun 30, 2023321–Form 10-Q (vrtx-20230630.htm, filed 2023-08-02) ↗
Q1 2023Mar 31, 2023295–Form 10-Q (vrtx-20230331.htm, filed 2023-05-02) ↗
Q4 2021Dec 31, 2021180-17.7%Form 10-K (vrtx-20211231.htm, filed 2022-02-09) ↗
Q3 2021Sep 30, 2021195-27.3%Form 10-Q (vrtx-20210930.htm, filed 2021-11-03) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Item 2(c) / Item 5 ($), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/qtr-buyback-avg-price

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?